Loading...
01/11 04:28
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several negative indicators: significant revenue and profit declines, increased losses, and missed financial metrics. Despite optimistic future projections and strategic contracts, the current financial health and lack of share repurchase plans contribute to a negative sentiment. The Q&A session highlighted management's vague responses and uncertainties around federal budget impacts and PFAS technology. These factors overshadow potential positive outcomes from future contracts and partnerships, leading to a negative outlook for the stock in the short term.
Total Revenue (Q4 2024) $14.7 million, a decrease of $8 million or 35.2% year-over-year due to lower volume and average pricing of waste, impacted by hurricanes in Florida, lower margin waste mix, and rescheduled waste receipts.
Total Revenue (Fiscal Year 2024) $59.1 million, a decrease of $30.6 million or 34.1% year-over-year, with treatment revenue down $8.5 million and services revenue down $22.1 million, affected by poor weather, prolonged effects of the continuing resolution, and R&D investments.
Gross Profit (Q4 2024) $594,000, down from $4.3 million in 2023, a decrease of $3.7 million due to lower revenue and higher labor and regulatory expenses.
Gross Profit (Fiscal Year 2024) Down $16.4 million year-over-year, impacted by lower revenue and lower margin waste/projects, with fixed costs up primarily from labor costs.
G&A Costs (Q4 2024) $3.9 million, slightly down from $4 million in Q4 2023, due to lower trade shows, sales commissions, and travel expenses.
G&A Costs (Fiscal Year 2024) $14.5 million, down from $15 million in 2023, attributed to lower sales-related expenses and incentive expenses.
Net Loss (Q4 2024) $3.5 million, compared to net income of $81,000 in Q4 2023, reflecting a significant decline.
Net Loss (Fiscal Year 2024) $20 million, compared to net income of $485,000 in 2023, including $8.2 million of noncash income tax expense.
Net Loss Per Share (Q4 2024) $0.22, compared to income per share of $0.01 in Q4 2023.
Net Loss Per Share (Fiscal Year 2024) $1.33 per share, compared to income per share of $0.04 in 2023.
EBITDA (Q4 2024) Loss of $3 million, compared to income of $434,000 in Q4 2023.
EBITDA (Fiscal Year 2024) Loss of $13.8 million, compared to income of $3.3 million in 2023.
Cash on Balance Sheet (End of 2024) $29 million, up from $7.5 million at year-end 2023, primarily from net proceeds of equity raises.
Current Liabilities (End of 2024) Down $4 million due to timing of payments and decreased operating expenses.
Working Capital (End of 2024) $28.2 million, compared to $4.5 million last year.
Cash Used by Continuing Operations (2024) $14.1 million.
Cash Provided by Financing (2024) $41 million, primarily from equity raises.
PFAS Destruction Technology: The Perma-FAS system has operated at a commercial scale, successfully meeting performance expectations. A second-generation Perma-FAS unit is scheduled for deployment in late Q3, expected to triple processing capacity and incorporate chemical recycling capabilities.
Market Expansion in Industrial Waste: Expansion in the industrial waste market under the Perma-Fix Flora facility, broadening client base to larger government contracts for hazardous materials in the Southeast region.
International Market Expansion: Continued expansion in international markets, particularly in Canada, Mexico, and Europe, with the GRC project in Italy on track for treatment operations beginning in late 2026.
Operational Efficiencies: Added plant operating shifts at key facilities to meet rising demand and implemented cost reduction measures within the Nuclear Services segment to align expenses with revenue backlog.
Strategic Shift in Leadership: Appointment of Troy Eshelman as Chief Operating Officer, effective January 23, 2025, to optimize operations and execute growth strategy.
Focus on DFLAW Program: The direct-feed low-activity waste program at Hanford is on track to begin initial tank waste treatment operations this summer, with significant long-term growth potential.
Project Delays: Ongoing delays in project starts, procurement cycles, and waste receipts due to federal budget resolution issues, leading to revenue shortfalls.
Federal Budget Uncertainties: Federal budget delays impacted procurement cycles, affecting revenue and project timelines, particularly for DOE and DOD opportunities.
Revenue Decrease: Total revenue decreased by 35.2% in Q4 2024 compared to Q4 2023, attributed to lower waste volumes, pricing, and lack of large projects.
Cost Management: Implemented cost reduction measures in response to federal budget uncertainties, aligning expenses with revenue backlog.
Investment in R&D: Substantial investments in PFAS technology impacting financial results, although critical for long-term positioning.
Market Competition: Highly competitive environment for procurement bids, particularly for the USS enterprise decommissioning project.
Economic Factors: Economic uncertainties and federal budget adjustments may impact larger DOE and DOD clients, although expected to have limited effect on DFLAW waste receipts.
Direct-Feed Low-Activity Waste Program (DFLAW): Expected to begin initial tank waste treatment operations in summer 2025, with a legally binding milestone from DOE set for August 1.
West Valley Demonstration Project: A 10-year multibillion-dollar contract that began its transition in Q1 2025, expected to contribute to revenue growth through 2025.
PFAS Destruction Technology: Deployment of a second-generation Perma-FAS unit scheduled for late Q3 2025, expected to triple processing capacity.
Expansion in Industrial Waste Market: Broadening client base to larger government contracts for hazardous materials in the Southeast region.
International Market Expansion: Progress in Canada, Mexico, and Europe, with the GRC project in Italy on track for treatment operations beginning in late 2026.
Revenue Expectations for 2025: Expecting a return to growth and profitability in 2025, driven by a solid backlog and improving project execution.
Waste Treatment Backlog: Strengthened backlog with expected meaningful increase from Q4 levels.
Cost Management: Implemented cost reduction measures to align expenses with revenue backlog.
Long-term Growth Pipeline: Pursuing pipeline opportunities anticipated to be awarded in 2025 at various DOE and DOD sites.
Financial Outlook: Anticipating steady existing budgets through Q4 2025, limiting impact on waste receipts.
Share Repurchase Program: None
The earnings call summary presents a mixed outlook. Financial performance and shareholder returns show improvement, but the guidance lacks clarity, especially regarding margins and partnerships. Q&A insights reveal uncertainties in PFAS progress and waste treatment margins, balanced by strong backlog and potential contracts. No clear catalyst for a strong price movement is evident, leading to a neutral sentiment.
The earnings call highlights a significant improvement in gross profit and a reduced net loss, indicating better financial performance. The increase in waste backlog and the anticipated start of the Hanford project provide strong growth prospects. Despite challenges in the Services segment and regulatory delays, the company's strategic initiatives, such as the PFAS program and Gen II deployment, are promising. The Q&A session reflects confidence in overcoming operational hurdles. Overall, the positive financial trajectory and growth initiatives suggest a positive stock price movement.
The earnings call presents a mixed picture: modest revenue growth and improved gross profit are overshadowed by consistent net losses and negative EBITDA. The Q&A reveals potential in waste receipts and PFAS technology, but management's vague responses on margins and project timelines raise concerns. The absence of a share repurchase program and international expansion risks further balance the outlook. Overall, the stock is likely to remain stable, with no strong catalysts for significant movement.
The earnings call highlighted modest revenue growth and improved profitability metrics, but persistent net losses and cash decline are concerns. The Q&A revealed increased waste receipts from Hanford, but management's vague responses on margins and budget impacts raise uncertainties. The absence of a shareholder return plan and international expansion risks further temper sentiment. Despite potential PFAS demand growth, competitive pressures and no new partnerships or guidance adjustments limit positive catalysts. Overall, the mixed financial performance and strategic outlook suggest a neutral stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
